VPI PHARMS INC FDA Approval ANDA 208663

ANDA 208663

VPI PHARMS INC

FDA Drug Application

Application #208663

Application Sponsors

ANDA 208663VPI PHARMS INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 50MG BASE/VIAL0ETHACRYNATE SODIUMETHACRYNATE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2020-06-09STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

VPI PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208663
            [companyName] => VPI PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ETHACRYNATE SODIUM","activeIngredients":"ETHACRYNATE SODIUM","strength":"EQ 50MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/09\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-09
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.